Lyndon Box is a Cardiology physician. OpenAlex indexes 44 publications with 841 citations (h-index 15).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1906 Fairview Ave Ste 230
Caldwell, ID 836055432
Telephone
208-459-4667Provider last certified this registry record 24 Nov 2020.
Industry payments
27 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Shockwave Medical, IncProgram year20256 payments
- AstraZeneca Pharmaceuticals LPProgram year20257 payments
- Boston Scientific CorporationProgram year20254 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
77.8%Beta blocker21.1%Metoprolol Succinate60%Carvedilol20%Metoprolol Tartrate6%Sotalol5%Nebivolol Hcl4%Bisoprolol Fumarate3%Atenolol1%Propranolol Hcl Er1%Part D<11 patientsStatin17.4%Atorvastatin Calcium64%Rosuvastatin Calcium31%Pravastatin Sodium4%Simvastatin1%Part D<11 patients+ 15 more classes in this area
Blood & clotting
17.6%Factor Xa inhibitor10.2%Eliquis80%Xarelto20%Part D≥116 patientsP2Y12 inhibitor6.2%Clopidogrel87%Brilinta13%Part D≥102 patients+ 2 more classes in this area
Metabolism & gastrointestinal
4.4%SGLT2 inhibitor2.5%Farxiga77%Jardiance23%Part D≥27 patientsPotassium supplement1.9%Potassium Chloride100%Part D≥39 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- B-91 | Interventional Cardiologists’ Perspectives of Percutaneous Coronary Intervention at Ambulatory Surgical Centers
Journal of the Society for Cardiovascular Angiography & Interventions
2025 - Interventional Cardiologists' Perspectives on Percutaneous Coronary Intervention at Ambulatory Surgical Centers
Catheterization and Cardiovascular Interventions
2025 - Economic Barriers to Interventional Cardiology Care for Adults and Children With Congenital Heart Disease and Potential Policy Solutions: A SCAI Policy Statement
Journal of the Society for Cardiovascular Angiography & Interventions
2025 - SCAI Expert Consensus Statement on Percutaneous Coronary Intervention Without On-Site Surgical Backup
JACC: Cardiovascular Interventions
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”